It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
The US Food and Drug Administration (FDA) has issued what the agency terms an "early communication" about a potential, but yet to be confirmed, safety issue with Pfizer's smoking cessation drug Chantix, where a number of postmarketing cases have reported patients on Chantix experiencing suicidal thoughts and related erratic behaviour.
The information on the cases involved was given to the FDA by the drug maker Pfizer Inc, as part of ongoing post marketing safety monitoring.
* Nausea * Headache * Vomiting * Flatulence
* Insomnia * Aggressive and Erratic Behavior * Drowsiness
* Abnormal dreams * Dysgeusia (alteration in taste)
In November 2007, the FDA announced it had received post-marketing reports that patients using Chantix for smoking cessation had experienced several serious symptoms, including suicidal ideation and occasional suicidal behavior, erratic behavior, and drowsiness. It is unknown whether the psychiatric symptoms are related to the drug or to nicotine withdrawal symptoms, although not all patients had stopped smoking. The FDA recommended that health care professionals and patients watch for behavioral and mood changes.[5]
Following is a list of treatment-emergent adverse events reported by patients treated with CHANTIX during all clinical trials. The listing does not include those events already listed in the previous tables or elsewhere in labeling, those events for which a drug cause was remote, those events which were so general as to be uninformative, and those events reported only once which did not have a substantial probability of being acutely life-threatening.
EYE DISORDERS. Infrequent: Conjunctivitis, Dry eye, Eye irritation, Vision blurred, Visual disturbance, Eye pain.
GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS. Frequent: Chest pain, Influenza like illness, Edema, Thirst. Infrequent: Chest discomfort, Chills, Pyrexia.
INVESTIGATIONS. Frequent: Liver function test abnormal, Weight increased. Infrequent: Electrocardiogram abnormal, Muscle enzyme increased, Urine analysis abnormal.
NERVOUS SYSTEM DISORDERS. Frequent: Disturbance in attention, Dizziness, Sensory disturbance. Infrequent: Amnesia, Migraine, Parosmia...
REPRODUCTIVE SYSTEM AND BREAST DISORDERS. Frequent: Menstrual disorder. Infrequent: Erectile dysfunction. Rare: Sexual dysfunction.
RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS. Frequent: Epistaxis, Respiratory disorders. Infrequent: Asthma. Rare: Pleurisy, Pulmonary embolism.
Carcinogenesis
Carcinogenesis was not demonstrated in mice receiving varenicline up to 2 years. In male rats, brown fat tumors developed at an increased incidence when given doses 23-67 times the maximum human dose. This was not seen in female rats. The clinical relevance in humans is unknown.
Higher appetite: 47%
Weight gain: 21%
Irritability: 36%
Dry mouth & throat: 35%
Sleep disturbance:
Originally posted by anhinga
reply to post by palehorse23
...with those side effects? No way, the costs outweigh the smoking dangers since there's better ways to quit. Gradual, cold turkey, the 'tea tree oil' toothpicks/extracts are meant for quitting and this herb.
[edit on 23-11-2007 by anhinga]
Originally posted by anxietydisorder
You'll feel like crap, start puking, and fart like an old granny. Then if you don't kill someone you'll fall asleep and have weird dreams.:shk:
Higher appetite: 47%
Weight gain: 21%
Irritability: 36%
Dry mouth & throat: 35%
Sleep disturbance: